MAP3K5 and metabolic dysfunction-associated steatotic liver disease: Taken together, we identify a beneficial role for liver‐specific ASK1 expression in the prevention of obesity‐associated hepatic steatosis and liver fibrosis potentially through induction of autophagy that may have translational therapeutic implications to tackle the development of NAFLD and liver fibrosis in humans.